The presence of the CLDN18-ARHGAP26 mutation has been shown to facilitate the progression and metastasis of gastric cancer (GC) through the loss of CLDN18 function and the acquisition of ARHGAP26 functions42. Here, ARHGAP26 is linked to gastric cancer.